IM Cannabis Corp. Files April 2025 6-K Report

Ticker: IMCC · Form: 6-K · Filed: 2025-05-05T00:00:00.000Z

Sentiment: neutral

Topics: reporting, foreign-private-issuer, sec-filing

TL;DR

IM Cannabis Corp. filed its monthly 6-K report with the SEC for April 2025.

AI Summary

IM Cannabis Corp. filed a Form 6-K for the month of April 2025, reporting as a foreign private issuer. The company, incorporated in Israel with its principal executive offices in Kibbutz Glil Yam, is involved in the medicinal chemicals and botanical products sector. This filing is routine and does not appear to contain specific financial or operational updates beyond its periodic reporting obligation.

Why It Matters

This filing indicates IM Cannabis Corp. is fulfilling its regular reporting requirements as a foreign private issuer with the SEC, which is standard for companies with international operations listed in the US.

Risk Assessment

Risk Level: low — This is a routine periodic filing by a foreign private issuer and does not contain new material information or financial disclosures.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers that is required to be filed with the SEC to provide information that the issuer makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.

What period does this specific Form 6-K cover?

This Form 6-K covers the month of April 2025.

What is IM Cannabis Corp.'s standard industrial classification?

IM Cannabis Corp.'s Standard Industrial Classification is MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833].

Where are IM Cannabis Corp.'s principal executive offices located?

IM Cannabis Corp.'s principal executive offices are located at Kibbutz Glil Yam, Central District, Israel.

Does this filing indicate a submission in paper format?

The filing includes checkboxes for submitting in paper as permitted by Regulation S-T Rule 101(b)(1) and 101(b)(7), but it does not explicitly state that this particular filing is being submitted in paper.

From the Filing

0001178913-25-001576.txt : 20250505 0001178913-25-001576.hdr.sgml : 20250505 20250505071952 ACCESSION NUMBER: 0001178913-25-001576 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20250506 FILED AS OF DATE: 20250505 DATE AS OF CHANGE: 20250505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IM Cannabis Corp. CENTRAL INDEX KEY: 0001792030 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40065 FILM NUMBER: 25910911 BUSINESS ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 BUSINESS PHONE: 416-256-4202 MAIL ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 6-K 1 zk2533106.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of April 2025 .   Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executive offices)   Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒  Form 40-F ☐   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____   Note : Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____   Note : Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.     SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.     IM CANNABIS CORP.   (Registrant)       Date: May 5, 2025 By: /s/ Oren Shuster   Name:     Oren Shuster   Title: Chief Executive Officer and Director EXHIBIT INDEX   99.1 Form 7 - Monthly Progress Report dated May 5, 2025 EX-99.1 2 exhibit_99-1.htm EXHIBIT 99.1 Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT   Name of Listed Issuer: IM Cannabis Corp. (the “ Issuer ” or “ IMC ” or the " Company ")   Trading Symbol: IMCC   Number of Outstanding Listed Securities as of 04/30/2025: 3,085,452 Common Shares.   Date: May 5, 2025   Report on Business   1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer was inactive disclose this fact.   • On April 11, 2025, the Issuer announced the following corporate updates:   Nasdaq Notification Letter   The Company has received a written notification (the “ Notification Letter ”) from the Nasdaq Stock Market LLC (&#822

View on Read The Filing